All In Biotech

Drug Trial Radar · NCT05232071

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

A Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With the Sodium-glucose Transport Protein 2 (SGLT2) Inhibitor EmpaGliflozin in patiEnts With Non-alcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

39

Actual

Start

Jun 29, 2022

Primary completion

May 8, 2024

Study completion Jun 4, 2024

Sponsor

Lead sponsor
Inventiva PharmaIndustry
Sponsor type
Industry
First posted
Feb 9, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study in the T2DM population is intended to confirm the lanifibranor effect versus placebo on glycemic control and assess a positive effect of the combination of lanifibranor with an SGLT2 inhibitor on glycemic control.

Conditions

  • NASH - Nonalcoholic Steatohepatitis
  • Diabetes Mellitus, Type 2

Interventions

  • LanifibranorDrug

    800 mg

  • PlaceboDrug

    Placebo to match

  • EmpagliflozinDrug

    10 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute Change in HbA1cTime frame: From Baseline to Week 24

Locations

42 sites in 5 countries. Site status is shown where the registry gives one.

  • Birmingham Digestive Health Research

    Homewood, Alabama

  • Institute for Liver Health dba Arizona Liver Health

    Chandler, Arizona

  • ARcare Center for Clinical Research

    Conway, Arkansas

  • ARcare Center for Clinical Research

    Little Rock, Arkansas

  • Cure Clinical Research, LLC

    Fountain Valley, California

  • Velocity Clinical Research

    Gardena, California

  • National Research Institute

    Huntington Park, California

  • Cadena Care Institute, LLC

    Poway, California

  • Florida Research Institute

    Lakewood Rch, Florida

  • Galenus Group

    Lehigh Acres, Florida

  • Prolive Medical Research

    Miami, Florida

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • Digestive Health Research of Southern California

    South Bend, Indiana

  • Tandem Clinical Research - New Orleans Area Site

    Marrero, Louisiana

  • Harvard Medical School

    Boston, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

  • AIG Digestive Disease Research

    Florham Park, New Jersey

  • Digestive Health Research

    Hermitage, Tennessee

  • Accelemed Research Institute

    Austin, Texas

  • Dallas Diabetes Research Center

    Dallas, Texas

  • American Research Corporation

    San Antonio, Texas

  • Diabetes & Glandular Disease Clinic, P.A.

    San Antonio, Texas

  • Impact Research Institute

    Waco, Texas

  • Digestive Health Research of North Texas

    Wichita Falls, Texas

  • University of Virginia

    Charlottesville, Virginia

  • Central Virginia VA Healthcare System

    Richmond, Virginia

  • CUB Erasme Hospital

    Brussels, Belgium

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • Universitair Ziekenhuis Antwerpen

    Edegem, Belgium

  • AZ Maria Middelares

    Ghent, Belgium

  • UZ GENT

    Ghent, Belgium

  • CHU Angers_Service d'hepatogastro-enterologie

    Angers, France

  • CHU Limoges

    Limoges, France

  • Hopital Saint Antoine

    Paris, France

  • CHU Bordeaux

    Pessac, France

  • Chu Rangueil

    Toulouse, France

  • HGE CHRU Nancy

    Vandœuvre-lès-Nancy, France

  • Amsterdam UMC

    Amsterdam, Netherlands

  • Hull University Teaching Hospital

    Hull, United Kingdom

  • King's College Hospital

    London, United Kingdom

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.